Create a Tribute Fund

Setting up a Closer to the Cure tribute fund online is a fitting way to remember and celebrate the life of someone special.

How your fund helps

Your Closer to a Cure tribute fund will support our life-changing work dedicated to stopping the devastating impact that arthritis has on people's lives.

More than 1 in 6 people of all ages struggle with the pain and disability of arthritis every day. Our work takes the pain away from people with arthritis, enabling them to remain active, doing the things they love.

Put simply, your tribute fund will help bring us closer to a future free from the pain and disability of arthritis.

Get In Touch With Us

Get in touch with us

We want MuchLoved to be a collaborative partnership. Our role as the MuchLoved team is to listen and respond to your suggestions and feedback so that we can improve the service for you.

If you need any help or have an idea or suggestion please feel free to contact us using the contact form below:

You can also call us during office working hours on 01494 722818

Alternatively please write to us if you prefer:

MuchLoved
Nash House
Repton Place
White Lion Road
Amersham
Buckinghamshire
HP7 9LP

MuchLoved is the working name of MuchLoved Limited, a social enterprise (No. 14965211).

What we do

Arthritis Research UK is the charity leading the fight against arthritis. Everything that we do is focused on taking the pain away and keeping people active. Our remit covers all conditions which affect the joints, bones and muscles, including osteoarthritis, rheumatoid arthritis, back pain and osteoporosis.

We fund research into the cause, treatment and cure of arthritis and we provide information on how to maintain healthy joints and bones, and how to live well with arthritis. We also champion the cause, influence policy change and work in partnership with others to achieve our aims.

We depend on public support and the generosity of our donors to keep doing this vital work.

Read more about what Arthritis Research UK does and find out the latest in arthritis research news.